Background illustration for clinical trials search

Paid Clinical Trials Alberta

Discover 818 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

for
Sickle Cell Disease
Location: Boston MA, Queens NY, The Bronx NY, Brooklyn NY,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 12+

Code: NCT06612268

Phase 3, Recruiting

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

for
Heart Failure
Location: Sherbrooke, Burlington VT, Norfolk VA, Greenville NC,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06033950

Phase 3, Recruiting

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

for
Heart Failure
Location: Sherbrooke, Montreal, Philadelphia PA, Norfolk VA,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06024746

Phase 3, Recruiting

A Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Systemic Juvenile Idiopathic Arthritis (SKYPS)

for
Juvenile Idiopathic Arthritis
Location: Calgary
Sponsor: Sanofi

Sex: All

Age: 1 - 17

Code: NCT02991469

Phase 2, Recruiting

Syncope Trial to Understand Tilt Testing or ECG Recording Tenth Prevention of Syncope Trial

for
Syncope
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 50 - 70+

Code: NCT05776810

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS

for
Relapsing Remitting Multiple Sclerosis (RRMS)
Location: St. John's, Halifax, Montreal, Sherbrooke, Quebec,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06733922

Recruiting

Study of Whether 15 mg Dose of Ketorolac IV is as Effective as a 30 mg Dose.

for
Pain, Pain, Postoperative
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 65

Code: NCT01230463

Recruiting

Getting Global Rare Disease Insights Through Technology Study

for
Metabolic Disease, Fabry Disease, Gaucher Disease,
Location: Calgary
Sponsor: M.A.G.I.C. Clinic LTD

Sex: All

Age: 18+

Code: NCT04758130

Recruiting

Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

for
Neurogenic Detrusor Overactivity
Location: Albany NY, Syracuse NY, Toronto, Jacksonville FL,
Sponsor: Urovant Sciences GmbH

Sex: All

Age: 2 - 17

Code: NCT05491525

Phase 2, Phase 3, Recruiting

Critical Delays in Cardiopulmonary Resuscitation During Simulated Obstetric Crisis: a Prospective Observational Study.

for
Maternal Death During Childbirth
Location: Calgary
Sponsor: KidSIM Simulation Program

Sex: All

Age: 18+

Code: NCT04050631

Recruiting

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension
Location: Boston MA, Valhalla NY, New York NY, Durham NC,
Sponsor: Inhibikase Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07365332

Phase 3, Recruiting

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

for
Asthma
Location: Trois-Rivieres, Greenville NC, Columbia MD, Windsor,
Sponsor: Sanofi

Sex: All

Age: 6+

Code: NCT07556159

Recruiting

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

for
Pulmonary Arterial Hypertension (PAH),
Location: Philadelphia PA, Washington D.C. DC, Jacksonville FL,
Sponsor: AllRock Bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07175038

Phase 2, Recruiting

Brivekimig for the Treatment of Moderate to Severe Hidradenitis Suppurativa

for
Hidradenitis Suppurativa
Location: Johnston RI, Quebec, New York NY, Chapel Hill NC,
Sponsor: Sanofi

Sex: All

Age: 18+

Code: NCT07170917

Phase 2, Recruiting

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Flushing NY, East Orange NJ, Philadelphia PA,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07190209

Phase 3, Recruiting

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Baltimore MD, Miami FL, DuBois PA,
Sponsor: Sanofi

Sex: All

Age: 40 - 70+

Code: NCT07053423

Phase 4, Recruiting

A Research Study to See How Well Weekly Insulin Icodec Maintains Blood Sugar Levels Compared to Daily Basal Insulins in Adults With Type 2 Diabetes

for
Diabetes Mellitus, Type 2
Location: Moncton, Levis, Quebec, Sherbrooke, Victoriaville,
Sponsor: Novo Nordisk A/S

Sex: All

Age: 18+

Code: NCT07112339

Recruiting

A Study to Investigate the Efficacy and Safety of Rilzabrutinib in Adult Participants With Graves' Disease

for
Graves' Disease
Location: Sherbrooke, Calgary, Surrey
Sponsor: Sanofi

Sex: All

Age: 18 - 70+

Code: NCT06984627

Phase 2, Recruiting

Cerebral Blood Flow and Ventilatory Responses During Sleep in Normoxia and Intermittent Hypoxia

for
Obstructive Sleep Apnea of Adult, Hypoxia, Brain, Sleep Apnea,
Location: Calgary
Sponsor: University of Calgary

Sex: All

Age: 18 - 45

Code: NCT03255408

Phase 1, Phase 2, Recruiting

Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)

for
Immune-related Adverse Event, Diarrhea, Advanced Melanoma,
Location: Edmonton
Sponsor: AHS Cancer Control Alberta

Sex: All

Age: 18+

Code: NCT05663775

Phase 2, Recruiting

Popular cities in Alberta